Wednesday, May 03, 2017 1:17:36 PM
Phoenix, April 27, 2017 (GLOBE NEWSWIRE) -- / CR-10 Disinfectant, the disruptive and eco-friendly disinfectant from BioNovelus Inc. (ONOV) has been approved by the Ministerio de Salud Pública – Guatemala’s ministry of health – for use as a disinfectant.
This is expected to come as welcome news to farmers in Guatemala concerned with the safety of their crops post-harvest. Although there are other solutions for disinfection available, management believes that our CR-10 Disinfectant is safer, easier to use, less harmful to the environment and more effective in killing sources of foodborne poisoning than the toxic chemicals and ammonium-based products traditionally used in post-harvest sanitation.
It also comes as welcome news to BioNovelus President, CEO and founder, Jean Ekobo, who has worked hard with his team for approval and registration from the Ministry. “We are happy that we can now finally sell CR-10 Disinfectant in Guatemala. We are looking forward to starting sales in this country.”
About CR-10 Disinfectant
Research has shown that CR-10 Disinfectant kills bacteria and viruses on contact, including E. coli, Salmonella, Clostridium difficile (C. difficile), Campylobacter, Norwalk virus (Norovirus), and others [Source: Dr. M. Oule´, Ph.D. of Canada’s University of Saint Boniface]. BioNovelus’ management believes that CR-10 is safer, easier, and more effective in killing these sources of foodborne poisoning than commonly used toxic chemicals such as bleach, alcohol, or quaternary ammonium-based products.
According to Dr. Oulé, CR-10 Disinfectant is organic, non-toxic, 100 percent biodegradable, and has a longer efficacy life span protection effect. Because of this, the Company believes CR-10 has the potential to be a real gamechanger in the food biosecurity space.
Recent CTM News
- Castellum, Inc. Announces New Strategic Alliance • GlobeNewswire Inc. • 04/18/2024 10:45:00 AM
- Castellum, Inc. Announces 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 10:45:00 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/27/2024 10:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:33:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:02:34 PM
- Castellum, Inc. Announces Closing of $4 Million Revolver with Live Oak Bank • GlobeNewswire Inc. • 02/23/2024 11:45:00 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/16/2024 09:43:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 11:31:23 AM
- Castellum Announces Closing of $2.7 Million Registered Direct Offering • GlobeNewswire Inc. • 01/29/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:32:36 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/29/2024 11:31:16 AM
- Castellum Announces Pricing of $2.7 Million Registered Direct Offering • GlobeNewswire Inc. • 01/25/2024 01:55:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:24 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/01/2023 09:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:08:32 PM
- Castellum, Inc. Announces Execution of Debt Term Sheet • GlobeNewswire Inc. • 11/27/2023 11:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:06:08 PM
- Castellum, Inc. Announces Third Quarter Financial Results • GlobeNewswire Inc. • 11/14/2023 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:05:41 PM
- Castellum, Inc. Announces Bob Eisiminger, as Senior Advisor • GlobeNewswire Inc. • 10/31/2023 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:04:03 PM
- Castellum, Inc. Announces 2024 Budget Targets and Strategic Initiatives • GlobeNewswire Inc. • 10/20/2023 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:15:24 PM
- Castellum Announces the Award of a $3 million Contract to its Specialty Systems, Inc. Subsidiary • GlobeNewswire Inc. • 08/29/2023 10:45:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM